共 50 条
- [22] Evans’ syndrome induced by atezolizumab plus bevacizumab combination therapy in advanced hepatocellular carcinoma Clinical Journal of Gastroenterology, 2023, 16 : 402 - 406
- [25] Pathological complete response of hepatocellular carcinoma confirmed by conversion hepatectomy following atezolizumab plus bevacizumab therapy: a case report and literature review Clinical Journal of Gastroenterology, 2024, 17 : 292 - 299
- [27] Bevacizumab-Induced Esophageal Perforation: A Case Report AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S982 - S983
- [28] A Case of Hepatocellular Carcinoma Successfully Resumed Atezolizumab and Bevacizumab After Associated Grade 3 Diarrhea and Grade 2 Colitis: Case Report and Literature Review ONCOTARGETS AND THERAPY, 2022, 15 : 1281 - 1288
- [29] Transthyretin Cardiac Amyloidosis Mimicking Immune Checkpoint-Induced Myocarditis in a Patient Treated with Atezolizumab and Bevacizumab for Advanced Hepatocellular Carcinoma: A Case Report CASE REPORTS IN ONCOLOGY, 2022, 15 (03): : 967 - 973
- [30] Atezolizumab and Bevacizumab in Hepatocellular Carcinoma REPLY NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (07): : 695 - 695